Intrinsic Value of S&P & Nasdaq Contact Us

Autolus Therapeutics plc AUTL NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • GB • USD

SharesGrow Score
43/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$8.87
+491.3%

There have been 21 recent insider transactions recorded for Autolus Therapeutics plc (AUTL), including 0 buys and 0 sells.

Notable insiders with recent activity include Young William D, Bonney Michael W, Butitta Cynthia M. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.

Insider Transactions — AUTL

Date Name Role Transaction Shares Avg. Price Value Shares Owned
2026-03-18 Young William D Director Unknown 80,000 $2.32 $185.6K -
2026-03-18 Bonney Michael W Director Unknown 80,000 $2.32 $185.6K -
2026-03-18 Butitta Cynthia M Director Unknown 80,000 $2.32 $185.6K -
2026-03-18 Berriman John E Director Unknown 80,000 $2.32 $185.6K -
2026-03-18 Itin Christian Chief Executive Officer Unknown 150,000 $9.02 $1.35M -
2026-03-18 Bain Linda Director Unknown 80,000 $2.32 $185.6K -
2026-03-18 Azelby Robert Director Unknown 80,000 $2.32 $185.6K -
2026-03-18 Driggs Alex SVP, Legal Affairs and Gc Unknown 22,500 $9.02 $202.95K -
2026-03-18 Iannone Robert Director Unknown 80,000 $2.32 $185.6K -
2026-03-18 Rao Madduri Ravin Director Unknown 80,000 $2.32 $185.6K -
2026-03-18 Dolski Robert Chief Financial Officer Unknown 83,300 - - -
2026-03-18 Leiderman Elisabeth Director Unknown 80,000 $2.32 $185.6K -
2026-03-18 Piccina Cintia U.s. Cco & Country Gen Manager Unknown 33,000 - - -
2026-03-18 Swan Alexander Chief Human Resources Officer Unknown 45,000 $9.02 $405.9K -
2026-03-18 Mcilvenny Patrick Paul SVP Finance Unknown 33,000 - - -
2026-03-18 Vann Christopher Andrew Chief Operating Officer Unknown 80,000 $9.02 $721.6K -
2026-03-18 Williams Christopher Michael James Chief Business Officer Unknown 45,000 $9.02 $405.9K -
2026-03-18 Pule Martin Anton Director Unknown 70,000 $9.02 $631.4K -
2026-03-18 Will Matthias Chief Development Officer Unknown 83,300 - - -
2026-03-18 Neville Miranda Suzette Chief Technology Officer Unknown 20,000 $9.02 $180.4K -
2026-03-18 Richardson Ryan Director Unknown 80,000 $1.41 $112.8K -
Informative Buy/Sell — open market transaction (most significant) Uninformative Buy — award, option exercise, conversion Uninformative Sell — tax withholding, award vest sale Neutral — gift, trust, expiry
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message